Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

Fidelity says PVCT is invalid symbol now. Anyone

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
smt232 Member Profile
 
Followed By 0
Posts 41
Boards Moderated 0
Alias Born 01/15/14
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2014 6:05:28 AM
Provectus Biopharmaceuticals Extends Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Indus... "Business Wire" - 11/14/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2014 6:34:28 AM
Provectus Biopharmaceuticals’ Protocol for Phase 3 Study Of PV-10 As Treatment for Melanoma Now Available Online "Business Wire" - 11/13/2014 6:00:00 AM
Provectus Biopharmaceuticals PV-10 Data Presented at SITC 29th Annual Meeting "Business Wire" - 11/10/2014 8:56:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/10/2014 6:13:10 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/6/2014 4:31:54 PM
Provectus Biopharmaceuticals, Inc. Reports Third Quarter Results "Business Wire" - 11/6/2014 4:31:00 PM
Provectus Biopharmaceuticals Submits PV-10 Phase 3 Melanoma Protocol to FDA "Business Wire" - 11/6/2014 4:00:00 PM
Provectus Biopharmaceutals Announces Abstract Available on Intralesional PV-10 & Co-Inhibitory Blockade Data for SITC 29th An... "Business Wire" - 11/6/2014 1:22:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/6/2014 12:52:36 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/6/2014 6:08:48 AM
Provectus Biopharmaceuticals, Inc. to Hold Quarterly Conference Call Today at 4 PM Eastern Standard Time "Business Wire" - 11/6/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/31/2014 6:31:39 AM
Provectus Biopharmaceuticals, Inc. to Hold Quarterly Conference Call on Thursday, November 6, 2014 "Business Wire" - 10/31/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/28/2014 6:02:40 AM
Provectus’ Intralesional PV-10 Clinical Data Published in the Annals of Surgical Oncology "Business Wire" - 10/28/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2014 6:00:08 AM
Provectus’ Intralesional PV-10 Clinical Data to Be Presented to the 2014 International Congress of the Society for Melanoma... "Business Wire" - 10/16/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/15/2014 6:04:52 AM
Provectus’ Intralesional PV-10 and Co-Inhibitory Blockade Data to Be Presented at SITC 29th Annual Meeting "Business Wire" - 10/15/2014 6:00:00 AM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 10/15/2014 5:59:30 AM
INC Research Signs Agreement to Perform FDA Due Diligence Audit of Regulatory Documents for Provectus Biopharmaceuticals "Business Wire" - 10/14/2014 9:53:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/14/2014 9:39:06 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/8/2014 6:00:54 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist